Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (5884)	11/6/1998 6:03:00 PM
From: Rocketman	Respond to of 9719

Thanks for the update on the ENMD presentations Monday and Tuesday. I guess I should put off a short until late Tuesday or Wednesday @;-> when the buy on rumor crowd sells on news. The only reason today's GERN reaction was more reasonable than ENMD was that the news came out yesterday mid day on a limited basis and those who were paying attention got in early rather than only during an opening rush. The big press releases came after the close. But, 4X from a day to day opening does seem a bit much for a research breakthrough with no profits from it for a decade or so. Rick, I must admit, I don't watch CNBC like I used to. And yes, they can drivel on about BS. I too have always liked Kernan the best, but he doesn't get enough air time. I still think that the general nature of the news draws investor attention to the sector for the long term and not just traders looking for the fast kill. But, those who are suckers will get eaten alive. Also, the frequency of good news has been going up a lot lately. Seems like the FDA is getting off their butts and doing something now that they actually have someone in charge there. Good that we now have all these overnight biotech experts to learn from and laugh at though. Nothing like reading a press release to get you up to speed quickly! Sure beats the decades we have into this industry, much more efficient. Good comment on the pre-1994 valuation. I think we are heading back into those heady days in the next few quarters. Sure would like to see the IPO and Secondary window open wide again too. Some of these companies need new fuel for the fire and I hate to see the Pharmas get to take advantage of a down market to buy up technology at fire sale prices. Rman